Highlights:
- CLV Frontier Brands Pty Ltd, a JV of LGC Capital, Creso
Pharma, and the Baltic Beer Company launches beverage business
unit.
- Estonian brewing facility is complete and currently
finalizing the development of a range of CLV beers and adult soft
drinks.
- Bottling of the first two beers is expected by mid-July 2018.
- Adult soft drinks are now in the final stage of
development.
- Brand websites preparing to go live with social media
campaigns ready for launch in the coming weeks.
- UK portfolio launch is set for September 2018.
Symbol: TSX-V: LG
MONTREAL, June 25, 2018 /CNW Telbec/ - LGC Capital
Ltd. (TSXV: LG) ("LGC") is pleased to announce that CLV
Frontier Brands Pty Ltd (CLV), a Joint Venture between LGC, Creso
Pharma and UK based Baltic Beer Company Ltd is progressing well,
with a number of products ready for commercial launch.
Facilities
State-of-the-art R&D brewery facility in Tallinn, Estonia is now complete and is being
fully utilized to research and develop a range of CLV beers and
adult soft drinks. Once market-ready, CLV has agreements in place
with brewing and bottling partners to produce the
products/beverages.
Beers
The first two beers soon to be released under the new CLV
umbrella beer brand OLD BOY MARY JANE (OBMJ) are fermenting
at the facilities of CLV's brewing partner. These two new
beers OBMJ Ghost Bog Hazy IPA and OBMJ Improper
Kölsch will be packed and ready for shipments during July with
updates on a firm release date expected shortly.
OBMJ Ghost Bog Hazy IPA and OBMJ Improper Kölsch will contain
unique terpene blends, which carry the flavour and aroma of
cannabis, but are not derived from cannabis and have no THC, CBD
nor any other cannabinoids.
The initial focus for these bottled beers is the UK followed by
other European and global markets. Discussions have already started
and are advanced in Canada
regarding licensed production in cans. Discussions are also in
progress with distributors in Australia, Israel and a number of other key markets.
Marketing and social media campaigns are being finalized and
will incorporate the branding tag line: 'Beer with
substance' and the landing page for OBMJ www.obmj.beer is due
to go live shortly.
Soft drinks
The first adult soft drink range will comprise a selection of
juice-based drinks containing various terpene blends. Recipe
testing production is due to start by the end of June 2018. These products will fall under the
newly created brand, GYPSY. The upcoming launch of the
brand website www.gypsydrinks.com will be the starting point for a
social media campaign which will promote Gypsy Sparkling
Water, Gypsy Adult Soft Drink and Gypsy Tonic
Water which are all due to be launched shortly. Official
branding remains confidential at this stage but will be released
just prior to commercial launch.
Director of Baltic Beer Company, Paul
Baxendale, is planning the sales and operational strategies
for Old Boy Mary Jane beers and the Gypsy drinks in the UK. The
portfolio launch kicks off in September
2018 at the Boutique Bar Show in London with a wider European launch planned
for October 2018 at the Anuga
Exhibition in Cologne Germany.
CLV will have wide-spread commercialisation reach across
numerous continents and intends to make full use of the networks of
all three companies for marketing and distribution, strictly in
compliance with all local and international laws.
Intellectual property
Trademark applications for Old Boy Mary Jane beers and Gypsy
have been submitted in numerous markets following intensive
research, and applications are progressing well.
John McMullen, CEO LGC
Capital, Ltd., stated; "After a successful product testing
meeting at CLV's offices in Tallinn,
Estonia, I believe this is another great leap forward for
LGC Capital and our partners Creso and the Baltic Beer Company. The
global beverage market has been expanding rapidly into the craft
beverage lines. With highly individualized and independent young
adults demanding a high-end selection of beverages to choose from,
CLV caters to this growing market and provides a connection with
flavours and experiences that the global consumer can fully enjoy.
"
Creso's Co-founder and CEO, Dr Miri Halperin Wernli,
said: "We are very excited about the imminent launch of
these unique creative products infused with natural organic terpene
blends that bring unusual and exciting flavours and aromas. We see
a lot of potential value in this growing market and anticipate a
successful initial portfolio launch in Europe. Through the vast geographic reach of
the three parties in this venture we can look forward to
opportunities for this innovative new range of drinks to be
produced and sold globally."
Paul Baxendale, Baltic Beer
Company's Managing Director and Sales and Marketing Director,
stated: "This is an exciting new direction for the drinks
industry. Terpenes can provide whole new layers of natural flavours
that you cannot get from traditional ingredients alone. The growth
of craft beers shows that consumers are not afraid to try something
different and we aim to offer an intriguing dimension
to both beers and non-alcoholic drinks."
On April 18, 2018, LGC announced
that the TSX Venture Exchange had conditionally accepted LGC's
joint venture investment in CLV, subject to LGC filing standard
documentation with the Exchange.
About LGC (www.lgc-capital.com)
LGC Capital Ltd. is a Canadian incorporated public company
listed on the TSX Venture Exchange (TSXV: LG). LGC's
objective is to become a diversified business group with core
business divisions that provide shareholders with exposure to a
diverse range of businesses, products and services with an emphasis
on significant investments in global medical cannabis sector.
About Creso Pharma Ltd
(www.cresopharma.com)
Creso Pharma brings the best of cannabis to better the lives of
people and animals. It brings pharmaceutical expertise and
methodological rigor to the cannabis world and strives for the
highest quality in its products. It develops cannabis and
hemp derived therapeutic, nutraceutical, and life style products
with wide patient and consumer reach for human and animal health.
Creso uses GMP development and manufacturing standards for its
products as a reference of quality excellence with initial product
registrations in Switzerland. It has worldwide rights for a
number of unique and proprietary innovative delivery technologies
which enhance the bioavailability and absorption of
cannabinoids.
About Baltic Beer Company Ltd
(www.virubeer.com)
A UK-based company that created and markets an iconic Estonian
beer brand called Viru Premium Estonian Beer. Viru beer is
currently sold in numerous markets around the world including
Australia, China, UK, Italy and Mexico to name a few and has won multiple
awards including gold medals at Monde Selection, Brussels and the World Beer Championships
Chicago.
FORWARD-LOOKING STATEMENTS
This press release may
contain forward-looking statements with respect to LGC Capital Ltd.
("LGC") and CLV Frontier Brands Pty Ltd ("CLV"), and their
respective operations, strategy, investments, financial performance
and condition. These statements generally can be identified by use
of forward- looking words such as "may", "will", "expect",
"estimate", "anticipate", "intends", "believe" or "continue" or the
negative thereof or similar variations. The actual results and
performance of LGC and CLV could differ materially from those
expressed or implied by such statements. Such statements are
qualified in their entirety by the inherent risks and uncertainties
surrounding future expectations. Some important factors that could
cause actual results to differ materially from expectations
include, among other things, general economic and market factors,
competition, government regulation and the factors described under
"Risk Factors and Risk Management" in LGC's Management's Discussion
and Analysis for the fiscal year ended September 30, 2017, as filed on SEDAR
(www.sedar.com). The cautionary statements qualify all
forward-looking statements attributable to LGC and persons acting
on its behalf. Unless otherwise stated, all forward-looking
statements speak only as of the date of this press release and
neither LGC nor CLV has any obligation to update such statements,
except to the extent required by applicable securities laws.
Caution Regarding Press Releases
Neither the TSX
Venture Exchange nor its Regulation Service Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
SOURCE LGC Capital Ltd